Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
A novel contrastive Dual-Branch Network (CDB-Net) for robust EEG-Based Alzheimer's disease diagnosis
Zakaria Alouani1, Oussama El Gannour2, Shawki Saleh1
1EEIS Laboratory, ENSET of Mohammedia, Hassan II University of Casablanca, Mohammedia, Morocco.
Abstract:
Alzheimer's Disease (AD) is neurodegenerative disorder that causes cognitive decline, memory loss, confusion, and changes in behavior. Early and accurate detection is important for timely intervention, current diagnostic methods can be slow, expensive, and have limited sensitivity. Electroencephalography (EEG) offers a simple and non-invasive way to measure brain activity, and it has shown promise in supporting AD diagnosis. However, EEG signals are often affected by noise-such as muscle movement, blinking, or electrical interference-which can make it harder for models to give reliable results. To address these challenges, we introduce CDB-Net (Contrastive Dual-Branch Network), a deep learning model built to improve the accuracy and robustness of EEG-based AD classification. The model uses two parallel branches: one processes clean EEG data, while the other processes a noisy version of the same data. By training these branches together using contrastive learning, the model learns to focus on features that stay consistent even when the signal is distorted by noise. A classification head is trained jointly using cross-entropy loss for downstream diagnosis. We tested our method on a public EEG dataset and found that CDB-Net achieved 97.92% accuracy on clean data and 83.41% accuracy even under adversarial attacks (FGSM), outperforming traditional machine learning classifiers and deep learning baselines models. These results highlight the effectiveness of contrastive dual-branch learning in enhancing model generalization and robustness, positioning CDB-Net as a promising tool for reliable EEG-based clinical decision support in the context of Alzheimer's Disease diagnosis.

